Brain Fog News and Research

RSS

A common diabetes drug may prevent long COVID when taken early

Research supports metformin's efficacy in reducing long COVID symptoms, suggesting its use in acute COVID-19 cases could alleviate long-term health impacts.

3 Feb 2026

Depression and anxiety together raise long COVID risk in older women

Older women who have a history of both depression and anxiety had a 78% higher risk of developing long COVID after a SARS-CoV-2 infection, report University of California San Diego researchers in the Jan. 27, 2026 online edition of the journal Menopause.

27 Jan 2026

Trump policies at odds with emerging understanding of covid’s long-term harm

27 Jan 2026

Elevated tau in Long COVID patients raises risk for neurodegenerative diseases

A study of 227 individuals who experienced neuro cognitive difficulties post COVID-19 infection – such as headaches, vertigo, balance dysregulation, changes in taste/smell, and brain fog – displayed a significant increase in their blood plasma of a crucial protein called tau, which is found in nerves and especially in the brain.

19 Jan 2026

Long COVID symptom clusters that could reshape patient care

A systematic review of Long COVID identifies symptom clusters, highlighting fatigue and proposing a management framework for personalized treatment strategies.

12 Jan 2026

Genes and biological networks that drive long COVID risk

This study merges causal genetics and network theory, revealing 32 genes linked to long COVID, offering insights for diagnostics and personalized therapies.

19 Dec 2025

Unnecessary gluten-free diets may put children at risk

Understanding gluten-related disorders is crucial for pediatric nutrition, as gluten-free diets can pose health risks without appropriate medical supervision.

15 Dec 2025

Acupuncture improves breast cancer survivors' perceived cognitive impairment

Real and sham acupuncture were more effective at improving breast cancer survivors' perceived cognitive impairment compared with usual care, while real acupuncture was superior to sham acupuncture in improving objective cognitive function, according to results from the randomized ENHANCE phase II clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 9-12, 2025.

12 Dec 2025

Hidden infections may play a key role in driving long COVID symptoms

For millions suffering from long COVID, their persistent breathlessness, brain fog and fatigue remain a maddening mystery, but a group of leading microbiologists think they may have cracked the case.

10 Dec 2025

Poor lung gas exchange may help explain lingering brain symptoms in Long COVID

This study found that people with Long COVID more than two years after infection showed normal lung tests and brain structure, yet reported significant sleep and cognitive symptoms. Subtle correlations revealed that poorer lung gas exchange was linked with higher brain perfusion, worse sleep, and weaker executive function, suggesting a possible lung–brain connection.

25 Nov 2025

Testing nicotinamide riboside as a potential aid for long COVID recovery

Chao-Yi Wu, PhD, OT, from the Department of Neurology and Edmarie Guzmán-Vélez, PhD, of the Department of Psychiatry at Mass General Brigham, are the lead and senior authors of a paper published in eClinicalMedicine, "Effects of Nicotinamide Riboside on NAD+ Levels, Cognition, and Symptom Recovery in Long-COVID: A Randomized Controlled Trial."

14 Nov 2025

Study links dysautonomia to breathing problems in chronic fatigue patients

Chronic fatigue syndrome leaves patients exhausted and struggling with brain fog - and it typically gets worse after mental or physical exercise, a phenomenon called post-exertional malaise.

10 Nov 2025

Adults diagnosed with concussion face elevated risk of a traffic crash

Adults diagnosed with a concussion may be at about 50 per cent higher risk of a subsequent traffic crash, finds a new study from researchers at ICES and Sunnybrook Research Institute.

6 Nov 2025

Low-dose THC mitigates harmful side effects and inflammation caused by HIV treatment

Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy (ART), according to new research from Texas Biomedical Research Institute.

6 Nov 2025

Study highlights the need for nationwide menopause education program in the UK

More than three-quarters of women feel that they are not well-informed enough about menopause, according to a new study led by UCL researchers, highlighting the need for a nationwide menopause education programme.

21 Oct 2025

Discovery explains why women face higher risk of Alzheimer’s and multiple sclerosis

New research by UCLA Health has identified a sex-chromosome linked gene that drives inflammation in the female brain, offering insight into why women are disproportionately affected by conditions such as Alzheimer's disease and multiple sclerosis as well as offering a potential target for intervention.

15 Oct 2025